These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

795 related items for PubMed ID: 11597586

  • 1. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H, Baulmann J, Blume A, Unger T, Culman J.
    Brain Res; 2001 Oct 19; 916(1-2):11-21. PubMed ID: 11597586
    [Abstract] [Full Text] [Related]

  • 2. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
    Baulmann J, Spitznagel H, Herdegen T, Unger T, Culman J.
    Neuroscience; 2000 Oct 19; 95(3):813-20. PubMed ID: 10670449
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P, Regoli D, Couture R.
    Br J Pharmacol; 1994 May 19; 112(1):240-9. PubMed ID: 7518304
    [Abstract] [Full Text] [Related]

  • 4. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
    Culman J, Wiegand B, Spitznagel H, Klee S, Unger T.
    Br J Pharmacol; 1995 Mar 19; 114(6):1310-6. PubMed ID: 7542533
    [Abstract] [Full Text] [Related]

  • 5. Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9,MET(O2)11]substance P.
    Yip J, Chahl LA.
    Neuroscience; 1999 Mar 19; 94(2):663-73. PubMed ID: 10579226
    [Abstract] [Full Text] [Related]

  • 6. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U, Zhao Y, Hunt SP, Culman J.
    Neuropharmacology; 2012 Nov 19; 63(6):958-65. PubMed ID: 22771977
    [Abstract] [Full Text] [Related]

  • 7. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
    Lessard A, Couture R.
    Br J Pharmacol; 2001 Dec 19; 134(8):1749-59. PubMed ID: 11739252
    [Abstract] [Full Text] [Related]

  • 8. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
    Yip J, Chahl LA.
    Br J Pharmacol; 1997 Oct 19; 122(4):715-25. PubMed ID: 9375969
    [Abstract] [Full Text] [Related]

  • 9. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist senktide.
    Smith ME, Flynn FW.
    J Comp Neurol; 2000 Oct 23; 426(3):413-28. PubMed ID: 10992247
    [Abstract] [Full Text] [Related]

  • 10. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
    Culman J, Klee S, Ohlendorf C, Unger T.
    J Pharmacol Exp Ther; 1997 Jan 23; 280(1):238-46. PubMed ID: 8996202
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E, Barbot L, Regoli D, Couture R.
    Br J Pharmacol; 1997 Oct 23; 122(4):643-54. PubMed ID: 9375960
    [Abstract] [Full Text] [Related]

  • 12. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
    Mazzone SB, Geraghty DP.
    Br J Pharmacol; 2000 Mar 23; 129(6):1121-31. PubMed ID: 10725260
    [Abstract] [Full Text] [Related]

  • 13. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K, Couture R.
    Br J Pharmacol; 2005 Jul 23; 145(6):712-27. PubMed ID: 15895109
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
    Michaud N, Couture R.
    Neuropeptides; 2003 Dec 23; 37(6):345-54. PubMed ID: 14698677
    [Abstract] [Full Text] [Related]

  • 15. Blockade of tachykinin NK1/NK2 receptors in the brain attenuates the activation of corticotrophin-releasing hormone neurones in the hypothalamic paraventricular nucleus and the sympathoadrenal and pituitary-adrenal responses to formalin-induced pain in the rat.
    Culman J, Das G, Ohlendorf C, Haass M, Maser-Gluth C, Zuhayra M, Zhao Y, Itoi K.
    J Neuroendocrinol; 2010 May 23; 22(5):467-76. PubMed ID: 20210847
    [Abstract] [Full Text] [Related]

  • 16. Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline.
    Ding YQ, Lü BZ, Guan ZL, Wang DS, Xu JQ, Li JH.
    Neuroscience; 1999 May 23; 91(3):1077-85. PubMed ID: 10391485
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization.
    Prat A, Picard P, Couture R.
    Br J Pharmacol; 1994 May 23; 112(1):250-6. PubMed ID: 7518305
    [Abstract] [Full Text] [Related]

  • 18. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U, Fehmann H, Bredenbröker D, Klüber D, Lange A, Wichert P.
    Neuropeptides; 1999 Feb 23; 33(1):55-61. PubMed ID: 10657472
    [Abstract] [Full Text] [Related]

  • 19. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ, Naeem S, Patel IA, Walpole C, Urbán L.
    Acta Biol Hung; 1996 Feb 23; 47(1-4):129-44. PubMed ID: 9123986
    [Abstract] [Full Text] [Related]

  • 20. Secretin activates visceral brain regions in the rat including areas abnormal in autism.
    Welch MG, Keune JD, Welch-Horan TB, Anwar N, Anwar M, Ruggiero DA.
    Cell Mol Neurobiol; 2003 Oct 23; 23(4-5):817-37. PubMed ID: 14514034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.